Resolute efforts to cure hepatitis C: Understanding patients' reasons for completing antiviral treatment

Jack A Clark1, Allen L Gifford2

  • 1Edith Nourse Rogers Memorial Veterans Hospital, Bedford, MA, USA; Boston University School of Public Health, Boston, MA, USA jaclark@bu.edu.

Insights

Patients completing difficult hepatitis C antiviral treatment were motivated by desires for cure, avoiding negative outcomes, personal perseverance, and rehabilitation. These reasons highlight moral factors influencing treatment adherence and patient engagement in care.

Area of Science:

  • Hepatology
  • Infectious Diseases
  • Medical Sociology

Background:

  • Antiviral therapy for hepatitis C presents significant challenges, often with limited cure success.
  • Patients face stigma, associated with substance misuse, impacting treatment candidacy and adherence.
  • Existing clinical discourse prioritizes adherence issues over patient motivations for completing treatment.

Purpose of the Study:

  • To explore the reasons why patients successfully completed antiviral treatment for hepatitis C.
  • To understand the patient perspective beyond adherence and expected failures.

Main Methods:

  • Qualitative interviews were conducted with patients who recently finished hepatitis C antiviral treatment.
  • Narrative accounts were analyzed to identify key themes and motivations.

Main Results:

  • Four primary reasons for treatment completion emerged: seeking cure, avoiding adverse outcomes, demonstrating perseverance, and achieving personal rehabilitation.
  • Patient motivations were linked to moral rationales addressing the social stigma of hepatitis C.
  • Reasons for completion may also reflect patient selection processes for treatment.

Conclusions:

  • Understanding the moral context of treatment can identify strategies to better support patients.
  • Exploring patient motivations offers insights into engagement with hepatitis C care.
  • Patient-centered approaches are crucial for improving treatment completion rates.

Related Concept Videos

Hepatitis01:25

Hepatitis

Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver.
66
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow01:26

Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow

Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug...
370
Viral Hepatitis I: Introduction01:28

Viral Hepatitis I: Introduction

Viral hepatitis is an inflammatory condition of the liver caused by infection with hepatotropic viruses, most commonly hepatitis A, B, C, D, and E. Despite variations in structure and transmission, all viruses mentioned infect hepatocytes and provoke immune responses that can hinder liver function. Additionally, some non-hepatotropic viruses can also lead to hepatic inflammation.Hepatitis A VirusHepatitis A virus (HAV) is transmitted through the fecal–oral route, typically by ingestion...
15
Hepatic Drug Excretion: Influencing Factors01:16

Hepatic Drug Excretion: Influencing Factors

The biliary system of the liver, crucial for bile secretion and drug excretion, comprises intrahepatic bile ducts that merge to form the common hepatic duct. This duct, carrying hepatic bile, combines with the cystic duct, draining the gallbladder and forming the common bile duct, which empties into the duodenum. Bile, produced by hepatic cells lining the bile canaliculi, is composed primarily of water, bile salts, pigments, electrolytes, and lesser amounts of cholesterol and fatty acids. Bile...
791
Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
947
Esophageal Varices-II: Clinical Features and Management01:28

Esophageal Varices-II: Clinical Features and Management

Esophageal varices often manifest as gastrointestinal bleeding episodes, presenting symptoms like hematemesis (vomiting of blood), hematochezia (passing fresh blood via the rectum), and melena (black, tarry stools). Other signs can include weight loss, anorexia, abdominal discomfort, jaundice, pruritus, altered mental status, and muscle cramps.
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
832